Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches

MLA

Johanna Erbani, et al. “Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-Selectin Receptor CD162 in Bone Marrow Niches.” Frontiers in Cell and Developmental Biology, vol. 8, July 2020. EBSCOhost, https://doi.org/10.3389/fcell.2020.00668.

APA

Johanna Erbani, Joshua Tay, Valerie Barbier, Jean-Pierre Levesque, & Ingrid G. Winkler. (2020). Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches. Frontiers in Cell and Developmental Biology, 8. https://doi.org/10.3389/fcell.2020.00668

Chicago

Johanna Erbani, Joshua Tay, Valerie Barbier, Jean-Pierre Levesque, and Ingrid G. Winkler. 2020. “Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-Selectin Receptor CD162 in Bone Marrow Niches.” Frontiers in Cell and Developmental Biology 8 (July). doi:10.3389/fcell.2020.00668.